Skip to content

The Effect of Electrode Implantation for Deep Brain Stimulation (DBS) on Brain Function Using Single Photon Emission Computed Tomography (SPECT) With Technetium-99m-ethyl Cysteinatedimer (Tc-ECD)

Exploring the Effect of Electrode Implantation for DBS on Brain Function During Rest and During Semantic Verbal Fluency Task Using SPECT With Tc-ECD

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01037686
Enrollment
120
Registered
2009-12-23
Start date
2006-02-28
Completion date
2010-10-31
Last updated
2009-12-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Deep Brain Stimulation, Parkinson's Disease

Keywords

PD, DBS

Brief summary

The goal of this study is to explore the effect of subthalamic nucleus (STN)-DBS surgery and stimulation in PD (Parkinson's disease) patients on regional cerebral blood (CBF) flow during cognitive task performance or at rest.

Detailed description

In this study subjects undergo SPECT scans for CBF mapping. PD patients before the surgery and healthy controls undergo two scans. PD patients after the surgery undergo four scans. PD patients who undergo two scans before the surgery, undergo only two scans after the surgery. Uptake of Tc-ECD, a CBF radiotracer, is done in the following conditions: * For PD patients before the surgery - during the performance of the semantic verbal fluency task or at rest (total of 2 scans). * For PD patients after the surgery- during the performance of the semantic verbal fluency task or at rest, either at on-stimulation or off-stimulation condition (total of 4 scans). The stimulator is turned off by the neurologist for 10 min. * PD patients before and after the surgery- during performance of the semantic verbal fluency task or at rest before the surgery and during performance of the semantic verbal fluency task or at rest after the surgery only at off-stimulation condition (Total of 4 scans). * Healthy controls - during the performance of the semantic verbal fluency task or at rest (total of 2 scans). Following the Tc-ECD injection, the subjects are scanned by Irix SPECT camera for 15min. Scans are analyzed and the regional CBF is measured using imaging software. Statistical analysis is done to discover the effect of the surgery, stimulation and the disease on blood flow at rest and during task performance. In addition, differences between groups in number of words produced during the task are also statistically analyzed.

Interventions

RADIATIONInjection of 15mCi of Tc-ECD and scanning by SPECT camera

All subjects (PD patients with or without DBS and healthy controls) will be injected with 15mCi of Tc-ECD and afterwards will be scanned by an Irix SPECT camera.

BEHAVIORALSemantic verbal fluency task performance

All Subjects (PD patients with or without DBS and healthy controls) before one of the two scans will perform the semantic verbal fluency task during the Tc-ECD uptake for 9 minutes. Before the other scan subjects will be at rest.

DEVICETurning off the stimulator

For PD patients treated with DBS, the neurologist will turn off the stimulator after the injection of Tc-ECD for ten minutes and then turn it back on.

Sponsors

Sheba Medical Center
Lead SponsorOTHER_GOV

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
BASIC_SCIENCE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
40 Years to 80 Years
Healthy volunteers
Yes

Inclusion criteria

* Progressive idiopathic PD * For control group - age-matched to study groups

Exclusion criteria

* Progressive dementia or other psychiatric disorders * Other neurological conditions * Other physical disease * Intolerance of off stimulation state * Involuntary head motions * Hearing deficits

Design outcomes

Primary

MeasureTime frame
CBF values in different brain regions3 months to 2 years post-surgery

Secondary

MeasureTime frame
Number of words produced in the semantic fluency task3 months to 2 years post-surgery

Countries

Israel

Contacts

Primary ContactSharon Hassin, MD
sharon.hassin@sheba.health.gov.il97235305791
Backup ContactYafit Kuttner, B.Sc
yafitkuttner@yahoo.com97235304753

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026